1. Home
  2. SHC vs PTCT Comparison

SHC vs PTCT Comparison

Compare SHC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

SELL

Current Price

$17.91

Market Cap

5.2B

Sector

Health Care

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$59.27

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SHC
PTCT
Founded
2015
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.5B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
SHC
PTCT
Price
$17.91
$59.27
Analyst Decision
Buy
Buy
Analyst Count
10
15
Target Price
$22.61
★ $100.33
AVG Volume (30 Days)
★ 1.8M
1.2M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
68.75
★ 264.48
EPS
0.28
★ 0.90
Revenue
★ $1,163,617,000.00
$264,734,000.00
Revenue This Year
$7.16
N/A
Revenue Next Year
$5.91
$9.47
P/E Ratio
★ $64.59
$67.73
Revenue Growth
5.74
★ 36.19
52 Week Low
$13.09
$58.80
52 Week High
$19.85
$90.87

Technical Indicators

Market Signals
Indicator
SHC
PTCT
Relative Strength Index (RSI) 42.82 34.70
Support Level $16.74 N/A
Resistance Level $18.77 $68.93
Average True Range (ATR) 0.49 1.93
MACD -0.03 -0.15
Stochastic Oscillator 24.83 13.82

Price Performance

Historical Comparison
SHC
PTCT

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: